09/09/2011 | Press release | Archived content
Celerity Partners is pleased to announce the acquisition of National Research Institute (NRI), a Los Angeles, CA based clinical research investigative site conducting late phase drug development studies on behalf of pharmaceutical and biotechnology companies.